Gulf Coast Biologics Knee Circle
CIRCLE OBJECTIVES
Burden-free data collection for various knee related pathologies in order to optimize effective and safe orthobiological applications.
Gulf Coast Biologics
FOUNDER
EmCyte Corporation
FUNDER

Circle Protocol

Endpoints:
VAS, WOMAC, IKDC
Timepoints:
0w, 2w, 6w, 3m, 6m, and 12m
Intervention:
PRP; BMAC; MFAT
Clinical Burden:
Patient Burden:
7-10 minutes per follow-up
Clinical Inputs:

MEMBER criteria

Subject to Circle Founder approval

CIRCLE ANALYTICS

21
CIRCLE MEMBERS
15149
DATA POINTS
158
TOTAL PATIENTS
158
TOTAL CASES
Updated on: May 17, 2023